Valuation: PharmaEssentia Corporation

Capitalization 30TCr 933.2Cr 804.89Cr 737.31Cr 696.71Cr 1.28TCr 90TCr 1.32TCr 8.79TCr 3.42TCr 43TCr 3.5TCr 3.43TCr 1,48500Cr P/E ratio 2026 *
34.4x
P/E ratio 2027 * 20.8x
Enterprise value 27TCr 855.55Cr 737.91Cr 675.96Cr 638.73Cr 1.18TCr 83TCr 1.21TCr 8.06TCr 3.14TCr 39TCr 3.21TCr 3.14TCr 1,36200Cr EV / Sales 2026 *
10.9x
EV / Sales 2027 * 7.35x
Free-Float
77.43%
Yield 2026 *
0.27%
Yield 2027 * 0.24%
1 day-1.24%
1 week+11.95%
Current month+20.42%
1 month+21.90%
3 months+9.79%
6 months+75.52%
Current year+69.36%
1 week 772
Extreme 772
859
1 month 578
Extreme 578
859
Current year 470
Extreme 470
859
1 year 428.03
Extreme 428.0317
859
3 years 246.91
Extreme 246.9067
859
5 years 62.18
Extreme 62.1772
859
10 years 48.3
Extreme 48.3
859
Manager TitleAgeSince
Chief Executive Officer - 01/01/2003
Director of Finance/CFO - 14/10/2015
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman - 01/09/2003
Director/Board Member - -
Director/Board Member - 30/06/2009
Change 5d. change 1-year change 3-years change Capi.($)
-1.24%+11.95%+75.62%+178.66% 933.2Cr
-0.73%-1.05%+32.40%+74.22% 4.94TCr
-0.25%-7.74%+66.73%+51.47% 4.52TCr
+0.24%-7.41%+58.24%+451.95% 2.33TCr
-1.19%-6.27%-10.24%-17.56% 2.22TCr
+0.42%-2.13%+37.23%-25.61% 1.74TCr
-0.09%-1.43%+23.97%-42.99% 1.58TCr
+1.95%-9.66%+39.56%+203.83% 1.33TCr
+1.72%-3.40%+30.06% - 1.28TCr
-2.35%-1.60%+8.91%+145.93% 1.22TCr
Average -0.15%-4.72%+36.25%+113.32% 2.21TCr
Weighted average by Cap. -0.25%-4.77%+38.46%+101.66%

Financials

2026 *2027 *
Net sales 2.49TCr 78Cr 68Cr 62Cr 59Cr 108Cr 7.6TCr 110.72Cr 738.8Cr 287.71Cr 3.58TCr 294.45Cr 288.17Cr 12TCr 3.68TCr 116.23Cr 100.25Cr 92Cr 87Cr 159.97Cr 11TCr 164Cr 1.09TCr 426.17Cr 5.3TCr 436.16Cr 426.86Cr 18TCr
Net income 880.4Cr 28Cr 24Cr 22Cr 21Cr 38Cr 2.69TCr 39Cr 261.51Cr 101.84Cr 1.27TCr 104.22Cr 102Cr 4.42TCr 1.43TCr 45Cr 39Cr 36Cr 34Cr 62Cr 4.37TCr 64Cr 424.53Cr 165.32Cr 2.05TCr 169.2Cr 165.59Cr 7.18TCr
Net Debt -2.46TCr -78Cr -67Cr -61Cr -58Cr -106.88Cr -7.52TCr -109.57Cr -731.17Cr -284.74Cr -3.54TCr -291.41Cr -285.2Cr -12TCr -2.49TCr -78Cr -68Cr -62Cr -59Cr -107.95Cr -7.59TCr -110.67Cr -738.48Cr -287.58Cr -3.57TCr -294.32Cr -288.05Cr -12TCr
Logo PharmaEssentia Corporation
PharmaEssentia Corp is a Taiwan-based company mainly engaged in the research, development, production and sale of new drugs. The Company is engaged in the research and development of new drugs, which are used for treatment of hematology, such as meloproliferative neoplasms (MPN), neutropenia, anemia; infectious disease, such as hepatitis C and hepatitis B; dermatology, such as psoriasis, and neurology, such as multiple sclerosis, among others. The Company’s products include KX01, P1101, Polycythemia Vera (PV), PEG-GCSF, PEG-EPO and others. The Company distributes its products within domestic market and to overseas markets.
Employees
131
Date Price Change Volume
19/26/19 796.00 NT$ -1.24% 35,74,884
18/26/18 806.00 NT$ -2.42% 45,45,275
15/26/15 826.00 NT$ +5.63% 69,62,306
14/26/14 782.00 NT$ 0.00% 66,55,502
13/26/13 782.00 NT$ +9.99% 73,95,909
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
796.00TWD
Average target price
778.83TWD
Spread / Average Target
-2.16%

Quarterly revenue - Rate of surprise